Insights On Trial Design
-
Retention Begins With Recruiting The Right-Fit Patients
11/13/2025
Recruiting the right patients into a clinical trial is only half the battle. To combat attrition, sponsors must also institute measures that ensure patients remain comfortable and confident throughout the trial.
-
Navigating Sensitive Country Requirements
2/1/2024
See how Scout expertly navigated complex regional laws and regulations to allow study patients in Iran access to treatment in Turkey.
-
Balancing Innovation, Ethics, and Operational Excellence in Adaptive Oncology Trials
1/30/2025
Experts discuss how to navigate the complexities of adaptive trial designs and how ethics reviews uphold patient safety, ensure informed consent, and provide robust oversight.
-
Clinical Leader Smart Sourcing Solutions Expo: Retention By Design
9/9/2025
Enhance participant retention through intuitive UX and real-time site support tools, while seamlessly integrating with IRT, EDC, and third-party platforms.
-
Think U.S.A.: The Operations Behind Your Clinical Trials
1/22/2025
Ready to think differently about early-phase clinical development? Check out the spotlight on our U.S. clinical facilities and the incredible teams behind them.
-
Breaking Down Operational And Financial Complexity In Clinical Trials
12/8/2025
Consider how factors like hybrid visits, enrollment patterns, and variable procedure volumes shape both the cadence and magnitude of site payments, supplier activity, and patient-related expenses.
-
Innovative Approaches In Oncology Clinical Trials
2/6/2025
By embracing innovative trial models and strategic collaborations, oncology CROs play a pivotal role in bringing novel cancer therapies to market efficiently and effectively.
-
DCTs And Community-Based Research Execution And Compliance
5/28/2025
The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.
-
5 Ways Integrated Drug Development Solutions Save Time And Money
10/16/2024
See how this approach can cut research timelines by up to 40%, helping sponsors efficiently navigate early-phase drug development.
-
Global Prevalence And Clinical Trials Landscape Of AML
4/8/2024
Explore the advancements in Acute Myeloid Leukaemia treatments, specifically innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.